دورية أكاديمية
Identifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation.
| العنوان: | Identifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation. |
|---|---|
| المؤلفون: | Hsu WC; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, United States of America; M.D./Ph.D. Combined Degree Program, University of Texas Medical Branch, Galveston, Texas, United States of America., Nenov MN; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, United States of America., Shavkunov A; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, United States of America., Panova N; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, United States of America., Zhan M; Department of Systems Medicine and Bioengineering, Weill Cornell Medical College, Methodist Hospital Research Institute, Houston, Texas, United States of America., Laezza F; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, United States of America; Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America; Center for Biomedical Engineering, University of Texas Medical Branch, Galveston, Texas, United States of America; Center for Addiction Research, University of Texas Medical Branch, Galveston, Texas, United States of America. |
| المصدر: | PloS one [PLoS One] 2015 Feb 06; Vol. 10 (2), pp. e0117246. Date of Electronic Publication: 2015 Feb 06 (Print Publication: 2015). |
| نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: San Francisco, CA : Public Library of Science |
| مواضيع طبية MeSH: | Fibroblast Growth Factors/*metabolism , Hippocampus/*metabolism , NAV1.6 Voltage-Gated Sodium Channel/*metabolism , Neurons/*metabolism , Protein Kinases/*metabolism , Signal Transduction/*physiology, Animals ; Fibroblast Growth Factors/genetics ; Genetic Complementation Test/methods ; HEK293 Cells ; Hippocampus/cytology ; Humans ; Luciferases/biosynthesis ; Luciferases/genetics ; NAV1.6 Voltage-Gated Sodium Channel/genetics ; Neurons/cytology ; Protein Kinase Inhibitors/pharmacology ; Protein Kinases/genetics ; Rats ; Signal Transduction/drug effects |
| مستخلص: | Kinases play fundamental roles in the brain. Through complex signaling pathways, kinases regulate the strength of protein:protein interactions (PPI) influencing cell cycle, signal transduction, and electrical activity of neurons. Changes induced by kinases on neuronal excitability, synaptic plasticity and brain connectivity are linked to complex brain disorders, but the molecular mechanisms underlying these cellular events remain for the most part elusive. To further our understanding of brain disease, new methods for rapidly surveying kinase pathways in the cellular context are needed. The bioluminescence-based luciferase complementation assay (LCA) is a powerful, versatile toolkit for the exploration of PPI. LCA relies on the complementation of two firefly luciferase protein fragments that are functionally reconstituted into the full luciferase enzyme by two interacting binding partners. Here, we applied LCA in live cells to assay 12 kinase pathways as regulators of the PPI complex formed by the voltage-gated sodium channel, Nav1.6, a transmembrane ion channel that elicits the action potential in neurons and mediates synaptic transmission, and its multivalent accessory protein, the fibroblast growth factor 14 (FGF14). Through extensive dose-dependent validations of structurally-diverse kinase inhibitors and hierarchical clustering, we identified the PI3K/Akt pathway, the cell-cycle regulator Wee1 kinase, and protein kinase C (PKC) as prospective regulatory nodes of neuronal excitability through modulation of the FGF14:Nav1.6 complex. Ingenuity Pathway Analysis shows convergence of these pathways on glycogen synthase kinase 3 (GSK3) and functional assays demonstrate that inhibition of GSK3 impairs excitability of hippocampal neurons. This combined approach provides a versatile toolkit for rapidly surveying PPI signaling, allowing the discovery of new modular pathways centered on GSK3 that might be the basis for functional alterations between the normal and diseased brain. |
| References: | Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1549-56. (PMID: 18579278) Mov Disord. 2006 Mar;21(3):396-401. (PMID: 16211615) J Physiol. 2005 Nov 15;569(Pt 1):179-93. (PMID: 16166153) Semin Cell Dev Biol. 2011 Apr;22(2):160-5. (PMID: 20950703) Mol Cell Neurosci. 2007 Mar;34(3):366-77. (PMID: 17208450) J Physiol. 2004 Nov 15;561(Pt 1):133-47. (PMID: 15388777) J Cell Biol. 2005 Feb 14;168(4):561-6. (PMID: 15699216) Neuroscience. 2003;116(2):477-84. (PMID: 12559102) Genome Biol. 2003;4(3):207. (PMID: 12620097) Neuropsychopharmacology. 2014 Mar;39(4):934-43. (PMID: 24141571) J Cell Sci. 2012 Dec 15;125(Pt 24):6058-70. (PMID: 23097049) Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4419-24. (PMID: 15070733) Cell. 2012 Jun 8;149(6):1245-56. (PMID: 22682247) Mol Cell Biol. 2006 Apr;26(8):2936-46. (PMID: 16581769) Biol Psychiatry. 1993 Apr 1;33(7):520-5. (PMID: 8513036) Mech Dev. 2000 Feb;90(2):283-7. (PMID: 10640713) Biol Psychiatry. 1999 Nov 15;46(10):1328-51. (PMID: 10578449) Am J Psychiatry. 2014 Apr;171(4):395-7. (PMID: 24687194) J Neurosci. 2007 Oct 31;27(44):12033-44. (PMID: 17978045) Front Psychiatry. 2014 Aug 21;5:109. (PMID: 25191280) J Alzheimers Dis. 2001 Apr;3(2):195-207. (PMID: 12214061) Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 1):2438-44. (PMID: 23563062) Curr Drug Targets. 2006 Nov;7(11):1421-34. (PMID: 17100582) Methods Mol Biol. 2011;756:395-425. (PMID: 21870242) J Biol Chem. 2006 Jun 9;281(23):16128-38. (PMID: 16527821) Neuropsychopharmacology. 2012 Jan;37(1):77-101. (PMID: 21900884) Annu Rev Biochem. 2011;80:769-95. (PMID: 21548788) Science. 1998 Sep 25;281(5385):2042-5. (PMID: 9748166) Science. 2010 May 14;328(5980):906-9. (PMID: 20466935) Eur J Neurosci. 2011 Nov;34(10):1609-19. (PMID: 22103418) Biol Psychiatry. 1996 Oct 1;40(7):568-75. (PMID: 8886289) J Neurosci. 2005 Jul 13;25(28):6621-30. (PMID: 16014723) Neuron. 2002 Jul 3;35(1):25-38. (PMID: 12123606) Neuropharmacology. 2009 Jun;56(8):1116-23. (PMID: 19328817) Immunity. 1998 Jan;8(1):31-41. (PMID: 9462509) J Cell Sci. 2010 Jan 15;123(Pt 2):286-94. (PMID: 20026642) Prog Biophys Mol Biol. 2005 May;88(1):59-90. (PMID: 15561301) Mol Cell Neurosci. 2009 Oct;42(2):90-101. (PMID: 19465131) J Biol Chem. 2013 Jul 5;288(27):19370-85. (PMID: 23640885) Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12288-93. (PMID: 15284440) CNS Drugs. 2013 Feb;27(2):135-53. (PMID: 23371914) ACS Chem Neurosci. 2012 Nov 21;3(11):857-72. (PMID: 23173067) Neurochem Res. 2007 Apr-May;32(4-5):577-95. (PMID: 16944320) Assay Drug Dev Technol. 2012 Apr;10(2):148-60. (PMID: 22364545) Mol Cell Neurosci. 2010 Dec;45(4):449-55. (PMID: 20708687) Sci Transl Med. 2012 Oct 10;4(155):155ps19. (PMID: 23052292) Semin Cell Dev Biol. 2011 Apr;22(2):153-9. (PMID: 20932926) EMBO J. 1999 Jan 4;18(1):188-97. (PMID: 9878062) Mol Cell Biol. 2004 Jan;24(1):71-83. (PMID: 14673144) J Biol Chem. 2011 Jun 3;286(22):19724-34. (PMID: 21487013) J Biol Chem. 2009 Jun 26;284(26):17883-96. (PMID: 19406745) Neuropsychopharmacology. 2011 Jun;36(7):1397-411. (PMID: 21389981) PLoS One. 2012;7(5):e37384. (PMID: 22649524) Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20523-8. (PMID: 18077363) Br J Pharmacol. 1997 Feb;120(4 Suppl):106-20; discussion 103-5. (PMID: 9142399) Mol Cell Neurosci. 2006 Sep;33(1):68-80. (PMID: 16875840) Int J Neuropsychopharmacol. 2004 Dec;7(4):387-90. (PMID: 15315719) Neuro Oncol. 2012 Jul;14(7):870-81. (PMID: 22711607) J Biol Chem. 1992 Aug 25;267(24):16878-82. (PMID: 1324914) J Neurosci. 2010 Apr 28;30(17):5830-42. (PMID: 20427644) Learn Mem. 2012 Mar;19(3):116-25. (PMID: 22366775) Nat Biotechnol. 2011 Nov;29(11):1039-45. (PMID: 22037377) Biochem J. 2003 Apr 1;371(Pt 1):199-204. (PMID: 12534346) Endothelium. 1997;5(2):95-105. (PMID: 9237043) Biochem J. 2007 Dec 15;408(3):297-315. (PMID: 17850214) J Psychopharmacol. 2012 May;26(5):714-23. (PMID: 22037925) ACS Chem Neurosci. 2012 Mar 21;3(3):151-60. (PMID: 22860184) Brain Res Bull. 2010 May 31;82(3-4):184-7. (PMID: 20347018) Nat Rev Neurosci. 2001 Jun;2(6):397-407. (PMID: 11389473) Nat Rev Drug Discov. 2007 Feb;6(2):115-20. (PMID: 17159925) Neurobiol Dis. 2007 Apr;26(1):14-26. (PMID: 17236779) Pharmacol Res. 2001 Nov;44(5):353-61. (PMID: 11712865) J Proteome Res. 2010 Apr 5;9(4):1976-84. (PMID: 20131913) Pharmacol Ther. 2010 Nov;128(2):281-304. (PMID: 20705090) |
| معلومات مُعتمدة: | R01 MH095995 United States MH NIMH NIH HHS; R01MH095995 United States MH NIMH NIH HHS |
| فهرسة مساهمة: | Note: Original DateCompleted: 20150210 |
| المشرفين على المادة: | 0 (NAV1.6 Voltage-Gated Sodium Channel) 0 (Protein Kinase Inhibitors) 0 (SCN8A protein, human) 0 (Scn8a protein, rat) 0 (fibroblast growth factor 14) 62031-54-3 (Fibroblast Growth Factors) EC 1.13.12.- (Luciferases) EC 2.7.- (Protein Kinases) |
| تواريخ الأحداث: | Date Created: 20150207 Date Completed: 20150330 Latest Revision: 20210218 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC4319734 |
| DOI: | 10.1371/journal.pone.0117246 |
| PMID: | 25659151 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!